Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Delivery Mode and Postpartum Psychiatric Conditions.

Obstetrics and gynecology·2026
Same author

Development and Application of an Algorithm to Identify the Primary Underlying Condition for Cases of Severe Maternal Morbidity.

Obstetrics and gynecology·2026
Same author

Anemia During Pregnancy in a U.S. Nationwide Cohort, 2018-2023.

Obstetrics and gynecology·2026
Same author

Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial.

Obstetrics and gynecology·2026
Same author

The California Perinatal Quality Care Collaborative: Together We Are Stronger.

Obstetrics and gynecology clinics of North America·2026
Same author

Pregnancy Outcomes Associated With Anemia in the First Trimester and Anemia Resolution by Late Pregnancy.

Obstetrics and gynecology·2026
Same journal

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.

Obstetrical & gynecological survey·2026
Same journal

A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

Obstetrical & gynecological survey·2026
Same journal

Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management.

Obstetrical & gynecological survey·2026
Same journal

Heavy Menstrual Bleeding in the Gynecology Clinic: A Call for Awareness and Standardized Screening for Underlying Bleeding Disorders.

Obstetrical & gynecological survey·2026
Same journal

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
Same journal

Female Sexual Dysfunction: Current Models and Treatment Options.

Obstetrical & gynecological survey·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

Interpregnancy interval and obstetrical complications.

Bat Zion Shachar1, Deirdre J Lyell

  • 1Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA. bshachar@stanford.edu

Obstetrical & Gynecological Survey
|September 20, 2012
PubMed
Summary
This summary is machine-generated.

The interpregnancy interval (IPI) impacts maternal and infant health. This review suggests a minimal IPI of 18 months, shorter for specific groups, to optimize outcomes.

More Related Videos

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Related Experiment Videos

Last Updated: May 18, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Area of Science:

  • Reproductive Medicine
  • Maternal-Fetal Medicine
  • Obstetrics

Background:

  • Interpregnancy interval (IPI) is crucial for maternal and infant health.
  • Short IPI is linked to adverse outcomes like preterm birth and low birth weight.
  • Long IPI is associated with preeclampsia and labor dystocia.

Purpose of the Study:

  • To review current data on interpregnancy interval (IPI) and its effects on maternal and perinatal health.
  • To explore optimal IPI recommendations for various maternal subgroups.
  • To reevaluate existing IPI guidelines based on recent evidence.

Main Methods:

  • Literature review of studies on interpregnancy interval (IPI).
  • Analysis of associations between IPI length and perinatal/maternal outcomes.
  • Examination of IPI in specific populations: prior cesarean, advanced maternal age, post-abortion/stillbirth.

Main Results:

  • Short IPI is associated with birth defects, schizophrenia, and autism.
  • Short IPI in women with prior cesarean increases uterine rupture risk.
  • Optimal IPI varies, with shorter intervals potentially beneficial after abortion or stillbirth.

Conclusions:

  • Current interpregnancy interval (IPI) recommendations may need revision.
  • A minimal IPI of 18 months is proposed, shorter for certain subgroups.
  • Personalized IPI recommendations are essential for optimizing maternal and infant outcomes.